期刊文献+

实行处方点评前后我院门诊处方质量比较分析 被引量:8

Analysis on quality of outpatient prescription before and after the implementation of prescription comment
下载PDF
导出
摘要 目的分析我院实行处方点评制度前后门诊处方质量的变化,包括用药的合理性以及处方书写的合格率。方法对2009年8、9月(处方点评前)及2010年1、2月间(处方点评后)我院门诊所有就诊患者处方进行抽查点评。由临床药师负责审查,将不合格处方筛选出来,分析不合格类型,并计算总的不合格处方比例、各专科的不合格处方比例、各种类型不合格处方所占的百分比。结果实行处方点评制度前、后,不合格处方率分别为21.43%、2.59%(P<0.01)。结论通过对医院不合格处方的审核工作,使得医生可以真正执行标准规范处方书写,促进临床合理用药。 Objective To compare and analyze the changes in quality of outpatient prescription before and after the implementation of comment on prescription.Methods The prescriptions of outpatients of our hospital from August to September in 2009 and from January to February in 2010 were sampled and commented.Unqualified prescriptions were screened out and classified by clinical pharmacists.The percentages of different types of unqualified prescriptions were calculated.Results The percentage of unqualified prescriptions was markedly reduced from 21.43% to 2.59% after prescription comments(P〈0.01).Conclusion The prescription writing could be standardized by the audit of unqualified prescription to promote the rational drug use.
出处 《实用药物与临床》 CAS 2011年第4期319-322,共4页 Practical Pharmacy and Clinical Remedies
关键词 处方点评 处方书写 合理用药 Prescription comment Prescription writing Rational drug use
  • 相关文献

参考文献10

二级参考文献37

共引文献76

同被引文献71

  • 1卫生部.医院处方点评管理规范(试行)[S]卫医管发[2010]28号.,..
  • 2国家药典委员编.《中华人民共和国药典·临床用药须知》(化学药和生物制品卷)[M].2010,北京:中国医药科技出版社,2011:303-316.
  • 3NCCN Clinical Practice Guidelines in Oncology: Antiemesis [S].2011.
  • 4Antiemetice : ASCO Clinical Practice Guideline Update [ S ]. 2011.
  • 5MASCC Clinical Practice Guidelines in Oncology:Antiemesis [S].2011.
  • 6NCCN Clinical Practice Guidelines in Oncology versionl, 2013. Antiemesis. National Comprehensive Cancer Network (NCCN)[ online ]. Available from URL : http ://www. nccn. org/professionals/physician_gls/PDF/antiemesis, pdf,2013 ).
  • 7Eisenberg P, Figueroa-Vadillo J, Zamora R, et al. Improved pre- vention of moderately emetogenic chemotherapy-induced nause- a and vomiting with palonosetron, a pharmacologically novel 5- HT3 receptor antagonist: Results of a Phase HI, single-dose trial versus dolasetron [J]. Cancer,2003,98 ( 11 ) :2473-2482.
  • 8刘欣.门诊处方点评及处方质量的分析[J].中国医院用药评价与分析,2014,14(7):165-166.
  • 9刘皈阳,魏宇宁,董圣惠,曹倩,张静.我院门诊处方评价方法及其结果分析[J].中国药房,2008,19(16):1262-1264. 被引量:41
  • 10刘艳秋,程兰英,张瑞珏.处方点评与合理用药[J].亚太传统医药,2008,4(9):112-113. 被引量:4

引证文献8

二级引证文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部